These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8640394)

  • 21. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis B among drug addicts].
    Laskus T; Lupa E; Radkowski M; Slusarczyk J
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):251-3. PubMed ID: 1437723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
    Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
    Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of liver damage in alcoholics and drug addicts].
    Marioni CF; Rapisarda L; Lussetti M; Perseghin P
    Recenti Prog Med; 1991 Nov; 82(11):577-80. PubMed ID: 1763228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A three-year survey of viral hepatitis in West London.
    Stewart JS; Farrow LJ; Clifford RE; Lamb SG; Coghill NF; Lindon RL; Sanderson IM; Dodd PA; Smith HG; Preece JW; Zuckerman AJ
    Q J Med; 1978 Jul; 47(187):365-84. PubMed ID: 715174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992].
    del Olmo JA; Añón C; Llovet F; Serra MA; Wassel A; Rodrigo JM
    Gastroenterol Hepatol; 1995 Oct; 18(8):405-9. PubMed ID: 7584778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HIV infection and hepatitis B co-infection: survey of prevalence in pregnant women in Bobo Dioulasso, Burkina Faso].
    Dao B; Nacro B; Dahourou H; Meda N; Van De Perre P
    Rev Med Brux; 2001 Apr; 22(2):83-6. PubMed ID: 11388027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coinfection with hepatitis viruses and human immunodeficiency virus in multiply transfused patients.
    Brenner B; Back D; Ben-Porath E; Hazani A; Martinowitz U; Tatarsky I
    Isr J Med Sci; 1994 Dec; 30(12):886-90. PubMed ID: 8002269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso.
    Simpore J; Savadogo A; Ilboudo D; Nadambega MC; Esposito M; Yara J; Pignatelli S; Pietra V; Musumeci S
    J Med Virol; 2006 Jun; 78(6):730-3. PubMed ID: 16628587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV infection in northwestern Sardinia].
    Cherchi GB; Mura MS; Calia MG; Gakis C; Ginanneschi R; Zara GM; Flumene A; Andreoni G
    Boll Ist Sieroter Milan; 1987; 66(6):448-52. PubMed ID: 3453147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of hepatitis C, B and D markers and histopathological aspects in a group of intravenous drug addicts].
    Lucidarme D; Foutrein P; Creusy C; Forzy G; Foutrein-Comes MC; Muyssen A; Bailly D; Parquet PJ; Filoche B
    Gastroenterol Clin Biol; 1994; 18(11):964-8. PubMed ID: 7705584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus as a possible cofactor in the development of fulminant hepatitis B in intravenous drug abusers.
    Lange WR; Moore JD; Cibull ML; Brutsche RL
    J Med; 1988; 19(3-4):203-14. PubMed ID: 3183532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of drug abuse fatalities and emergencies.
    Schulz-Schaeffer W; Schmoldt A; Peters T; Püschel K
    Forensic Sci Int; 1993 Nov; 62(1-2):161-6. PubMed ID: 8300031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic.
    Banatvala JE; Chrystie IL; Palmer SJ; Kenney A
    Lancet; 1990 Apr; 335(8693):859-60. PubMed ID: 1969586
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV-related deaths outside medical institutions in Stockholm.
    Rajs J; Karlsson T; Eklund B; Bergendahl K
    Forensic Sci Int; 1989 Jun; 41(3):269-80. PubMed ID: 2777160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deaths among drug abusers in south-east Scotland (1989-1994).
    Bentley AJ; Busuttil A
    Med Sci Law; 1996 Jul; 36(3):231-6. PubMed ID: 8918091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality and increasing drug use in Edinburgh: implications for HIV epidemic.
    Skidmore CA; Robertson JR; Savage G
    Scott Med J; 1990 Aug; 35(4):100-2. PubMed ID: 2237384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.